Search Results

There are 7650 results for: content related to: Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow

  1. You have free access to this content
    Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 54–60, Mitchell L. Shiffman and Rafael Esteban

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02718.x

  2. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  3. You have free access to this content
    Phase III results of Boceprevir in treatment naïve patients with chronic hepatitis C genotype 1

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 27–31, Michael P. Manns, Antoaneta A. Markova, Beatriz Calle Serrano and Markus Cornberg

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02725.x

  4. Boceprevir in liver transplant recipients

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 192–197, Sammy Saab, Vignan Manne, Sherona Bau, Justin A. Reynolds, Ruby Allen, Leonard Goldstein, Francisco Durazo, Mohammed El-Kabany, Steven Han and Ronald W. Busuttil

    Version of Record online : 10 APR 2014, DOI: 10.1111/liv.12548

  5. You have free access to this content
    How to optimize HCV therapy in genotype 1 patients with cirrhosis

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 46–55, Marc Bourlière, Astrid Wendt, Hélène Fontaine, Christophe Hézode, Stanislas Pol and Jean Pierre Bronowicki

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12067

  6. You have free access to this content
    Phase III results in Genotype 1 naïve patients: predictors of response with boceprevir and telaprevir combined with pegylated interferon and ribavirin

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 39–43, Paul Y. Kwo

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02709.x

  7. A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue s2, May 2012, Pages: 1–26, I. M. Jacobson, J.-M. Pawlotsky, N. H. Afdhal, G. M. Dusheiko, X. Forns, D. M. Jensen, F. Poordad and J. Schulz

    Version of Record online : 8 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01590.x

  8. You have free access to this content
    HCV therapy in HIV-infected patients

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 63–67, Mark S. Sulkowski

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12082

  9. You have free access to this content
    Hepatitis C virus-human immunodeficiency virus coinfection

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 129–134, Mark S. Sulkowski

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02719.x

  10. You have free access to this content
    Optimal treatment with boceprevir for chronic HCV infection

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 14–22, Benjamin Maasoumy and Michael P. Manns

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12070

  11. You have free access to this content
    Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver

    Liver International

    Volume 32, Issue 10, November 2012, Pages: 1477–1492, Vincent Leroy, Lawrence Serfaty, Marc Bourlière, Jean-Pierre Bronowicki, Patrick Delasalle, Alexandre Pariente, Stanislas Pol, Fabien Zoulim and Georges-Philippe Pageaux

    Version of Record online : 14 AUG 2012, DOI: 10.1111/j.1478-3231.2012.02856.x

  12. You have free access to this content
    Treating HCV in HIV 2013: on the cusp of change

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 53–59, Valérie Martel-Laferrière and Douglas T. Dieterich

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12396

  13. Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients

    Liver International

    Volume 35, Issue 9, September 2015, Pages: 2090–2099, Patrick Miailhes, Camille Gilbert, Karine Lacombe, Joop E. Arends, Massimo Puoti, Jürgen K. Rockstroh, Philippe Sogni, Hélène Fontaine, Eric Rosenthal, Maria Winnock, Marc-Arthur Loko, Linda Wittkop, François Dabis, Dominique Salmon and the ESCMID European Study Group on Viral Hepatitis

    Version of Record online : 23 FEB 2015, DOI: 10.1111/liv.12799

  14. Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 90–100, Jose L. Calleja, Juan M. Pascasio, Belén Ruiz-Antorán, Francisco Gea, Rafael Bárcena, Juan R. Larrubia, Ramón Pérez-Álvarez, Jose M. Sousa, Manuel Romero-Gómez, Ricard Solá, Juan de la Revilla, Javier Crespo, Jose M. Navarro, Juan I. Arenas, Manuel Delgado, Conrado M. Fernández-Rodríguez, Ramon Planas, Maria Buti, Xavier Forns and the Spanish Group for the Study of the Use of Direct-Acting Drugs Hepatitis C with Severe Fibrosis

    Version of Record online : 15 SEP 2014, DOI: 10.1111/liv.12656

  15. You have free access to this content
    Response-guided and -unguided treatment of chronic hepatitis C

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 64–73, K. Rajender Reddy, Frederick Lin and Fabien Zoulim

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02713.x

  16. You have free access to this content
    Boceprevir and telaprevir for the treatment of chronic hepatitis C: safety management in clinical practice

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 32–38, Christophe Hézode

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02707.x

  17. You have free access to this content
    Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 79–87, Philippe Halfon and Christoph Sarrazin

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02716.x

  18. Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVES

    Liver International

    Volume 36, Issue 9, September 2016, Pages: 1275–1283, Adeel A. Butt, Peng Yan, Obaid S. Shaikh, Raymond T. Chung, Kenneth E. Sherman and for the ERCHIVES study

    Version of Record online : 24 MAR 2016, DOI: 10.1111/liv.13103

  19. You have free access to this content
    Future treatment of patients with HCV cirrhosis

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 113–119, Marc Bourlière, Asma Khaloun, Claire Wartelle-Bladou, Valérie Oules, Isabelle Portal, Souad Benali, Xavier Adhoute and Paul Castellani

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02702.x

  20. Use of first-generation HCV protease inhibitors in patients coinfected by HIV and HCV genotype 1

    Liver International

    Volume 34, Issue 6, July 2014, Pages: 869–889, Dominique Salmon-Ceron, Cédric Arvieux, Marc Bourlière, Patrice Cacoub, Philippe Halfon, Karine Lacombe, Georges-Philippe Pageaux, Gilles Pialoux, Lionel Piroth, Isabelle Poizot-Martin, Eric Rosenthal and Stanislas Pol

    Version of Record online : 25 NOV 2013, DOI: 10.1111/liv.12363